Loading search results
'Home Sweet Home' Programme: Empowering the Patient and Caregiver for Early and Safe Discharge of Patients With Geriatric Hip Fractures
Sponsor study identifier
interventional
125
1 country
1
Study Start
September 5, 2019
Actual (reported)Primary Completion
June 8, 2023
Actual (reported)Study Completion
June 8, 2023
Actual (reported)Objective: To study whether fracture hip patients can be benefited from the empowerment program Hypothesis to be tested Primary hypothesis: empowerment program can improve the patient's functional recovery. Secondary hypothesis: the program can improve readmission rate, length of stay, and secondary fracture. Design and subjects This is a prospective randomised controlled trial and subjects are fracture hip patients Instruments Ipads are needed to show the videos of the rehabilitation program Interventions The empowerment program consists of three main areas which directly correspond to the contents that the patients and caregivers expressed as most needed in interviews conducted by the investigators during hip fracture patients' follow up:
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 8, 2023
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 5, 2019
Actual (reported)April 26, 2022
Actual (reported)May 26, 2022
Actual (reported)June 8, 2023
Actual (reported)June 8, 2023
Actual (reported)October 23, 2026
Actual (reported)Functional Scores - Modified Barthel Index (MBI)
The Modified Barthel Index (MBI) is an ordinal scale, often referred to as a 0-100 point total score or 0-100 point scale, used to quantify a patient's level of independence in activities of daily living (ADL). 0 indicates total dependence and 100 indicates total independence.
2 months follow-up
Functional Scores - Modified Barthel Index (MBI)
The Modified Barthel Index (MBI) is an ordinal scale, often referred to as a 0-100 point total score or 0-100 point scale, used to quantify a patient's level of independence in activities of daily living (ADL). 0 indicates total dependence and 100 indicates total independence.
6 months follow-up
Functional Scores - Modified Barthel Index (MBI)
The Modified Barthel Index (MBI) is an ordinal scale, often referred to as a 0-100 point total score or 0-100 point scale, used to quantify a patient's level of independence in activities of daily living (ADL). 0 indicates total dependence and 100 indicates total independence.
12 months follow-up
Functional Scores - EQ5D-Utility-Index
It is a widely used, generic, preference-based measure of health-related quality of life (HRQoL) representing societal preferences. It calculates a single summary utility score from five health dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression). Typically ranges between 0 (dead) and 1 (full health).
2 months follow-up
Survival Rate
6 months
Survival Rate
12 months
Survival Rate
24 months
Number of Subsequent Fracture
Within 12 months (1 year)
Second Admission Rate
Within 12 months (1 year)
Orthopaedic surgeon, geriatrician, physiotherapists, occupational therapists, and nurses will make videos (each 3-5 minutes long) which are available to the patients and caregivers during both the hospitalization period and after discharge. They will complement the therapists' training sessions and allow revision of the contents by the patients and caregivers anytime. The patients and caregivers will be asked to complete an assessment after they view the videos to reinforce the knowledge they learn in the videos. Caregivers can be patient's relatives, friends or domestic helper who can commit to visiting the patient at least two days per week during the early discharge period.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Queen Mary Hospital, The University of Hong Kong
Hong Kong, Hong Kong
Tak Man Wong
The University of Hong Kong
125 participants (actual enrollment reported by the registry).
First Submitted
April 26, 2022
First Posted
May 26, 2022
Study Start
September 5, 2019
Actual (reported)Functional Scores - EQ5D-Utility-Index
It is a widely used, generic, preference-based measure of health-related quality of life (HRQoL) representing societal preferences. It calculates a single summary utility score from five health dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression). Typically ranges between 0 (dead) and 1 (full health).
6 months follow-up
Functional Scores - EQ5D-Utility-Index
It is a widely used, generic, preference-based measure of health-related quality of life (HRQoL) representing societal preferences. It calculates a single summary utility score from five health dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression). Typically ranges between 0 (dead) and 1 (full health).
12 months follow-up
Functional Scores - EQ-QOL-VAS Value
EuroQoL Visual Analog Scale (EQ-VAS ) is a quantitative, self-reported measure of an individual's overall health-related quality of life, ranging from 0 to 100. It complements the EQ-5D descriptive system by providing a direct, subjective rating of "today's" health status, where 0 represents the worst imaginable health and 100 represents the best imaginable health. It reflects the patient's own perspective, rather than the general population's preferences (which are used for EQ-5D index values).
2 months follow-up
Functional Scores - EQ-QOL-VAS Value
EuroQoL Visual Analog Scale (EQ-VAS ) is a quantitative, self-reported measure of an individual's overall health-related quality of life, ranging from 0 to 100. It complements the EQ-5D descriptive system by providing a direct, subjective rating of "today's" health status, where 0 represents the worst imaginable health and 100 represents the best imaginable health. It reflects the patient's own perspective, rather than the general population's preferences (which are used for EQ-5D index values).
6 months follow-up
Functional Scores - EQ-QOL-VAS Value
EuroQoL Visual Analog Scale (EQ-VAS ) is a quantitative, self-reported measure of an individual's overall health-related quality of life, ranging from 0 to 100. It complements the EQ-5D descriptive system by providing a direct, subjective rating of "today's" health status, where 0 represents the worst imaginable health and 100 represents the best imaginable health. It reflects the patient's own perspective, rather than the general population's preferences (which are used for EQ-5D index values).
12 months follow-up
Functional Scores - EQ5D-5L Mobility
The EQ-5D-5L mobility dimension measures mobility using five levels: no problems, slight, moderate, severe, and unable to walk, providing high sensitivity. Mobility, often along with pain/discomfort, shows the highest health impairment, ranging from 1 to 5. Level 1 (No problem to walk) Level 2 (Slight problem to walk) Level 3 (Moderate problem to walk) Level 4 (Severe problem to walk) Level 5 (Unable to walk)
2 months follow-up
Functional Scores - EQ5D-5L Mobility
The EQ-5D-5L mobility dimension measures mobility using five levels: no problems, slight, moderate, severe, and unable to walk, providing high sensitivity. Mobility, often along with pain/discomfort, shows the highest health impairment, ranging from 1 to 5. Level 1 (No problem to walk) Level 2 (Slight problem to walk) Level 3 (Moderate problem to walk) Level 4 (Severe problem to walk) Level 5 (Unable to walk)
6 months follow-up
Functional Scores - EQ5D-5L Mobility
The EQ-5D-5L mobility dimension measures mobility using five levels: no problems, slight, moderate, severe, and unable to walk, providing high sensitivity. Mobility, often along with pain/discomfort, shows the highest health impairment, ranging from 1 to 5. Level 1 (No problem to walk) Level 2 (Slight problem to walk) Level 3 (Moderate problem to walk) Level 4 (Severe problem to walk) Level 5 (Unable to walk)
12 months follow-up
Functional Scores - EQ5D-5L-SELF-CARE
The EQ-5D-5L self-care dimension assesses a respondent's ability to wash or dress themselves, ranging from no problems to extreme inability. It features five severity levels to capture subtle changes in functioning, which measures the impact of health conditions on daily, personal care activities. Level 1 (I have no problems with self-care (e.g., washing or dressing)) Level 2 (I have slight problems with self-care) Level 3 (I have moderate problems with self-care) Level 4 (I have severe problems with self-care) Level 5 (I am unable to wash or dress myself (extreme problem))
2 months follow-up
Functional Scores - EQ5D-5L-SELF-CARE
The EQ-5D-5L self-care dimension assesses a respondent's ability to wash or dress themselves, ranging from no problems to extreme inability. It features five severity levels to capture subtle changes in functioning, which measures the impact of health conditions on daily, personal care activities. Level 1 (I have no problems with self-care (e.g., washing or dressing)) Level 2 (I have slight problems with self-care) Level 3 (I have moderate problems with self-care) Level 4 (I have severe problems with self-care) Level 5 (I am unable to wash or dress myself (extreme problem))
6 months follow-up
Functional Scores - EQ5D-5L-SELF-CARE
The EQ-5D-5L self-care dimension assesses a respondent's ability to wash or dress themselves, ranging from no problems to extreme inability. It features five severity levels to capture subtle changes in functioning, which measures the impact of health conditions on daily, personal care activities. Level 1 (I have no problems with self-care (e.g., washing or dressing)) Level 2 (I have slight problems with self-care) Level 3 (I have moderate problems with self-care) Level 4 (I have severe problems with self-care) Level 5 (I am unable to wash or dress myself (extreme problem))
12 months follow-up
Functional Scores - EQ5D-5L-USUAL-ACTIVITIES
The EQ-5D-5L Usual Activities dimension assesses how health problems affect a person's ability to perform daily tasks like work, study, housework, family, or leisure activities. Respondents choose one of five severity levels (no, slight, moderate, severe, or unable) based on their capacity to perform these functions today. Level 1 (No Problems: I have no problems doing my usual activities) Level 2 (Slight Problems: I have slight problems doing my usual activities) Level 3 (Moderate Problems: I have moderate problems doing my usual activities) Level 4 (Severe Problems: I have severe problems doing my usual activities) Level 5 (Unable: I am unable to do my usual activities)
2 months follow-up
Functional Scores - EQ5D-5L-USUAL-ACTIVITIES
The EQ-5D-5L Usual Activities dimension assesses how health problems affect a person's ability to perform daily tasks like work, study, housework, family, or leisure activities. Respondents choose one of five severity levels (no, slight, moderate, severe, or unable) based on their capacity to perform these functions today. Level 1 (No Problems: I have no problems doing my usual activities) Level 2 (Slight Problems: I have slight problems doing my usual activities) Level 3 (Moderate Problems: I have moderate problems doing my usual activities) Level 4 (Severe Problems: I have severe problems doing my usual activities) Level 5 (Unable: I am unable to do my usual activities)
6 months follow-up
Functional Scores - EQ5D-5L-USUAL-ACTIVITIES
The EQ-5D-5L Usual Activities dimension assesses how health problems affect a person's ability to perform daily tasks like work, study, housework, family, or leisure activities. Respondents choose one of five severity levels (no, slight, moderate, severe, or unable) based on their capacity to perform these functions today. Level 1 (No Problems: I have no problems doing my usual activities) Level 2 (Slight Problems: I have slight problems doing my usual activities) Level 3 (Moderate Problems: I have moderate problems doing my usual activities) Level 4 (Severe Problems: I have severe problems doing my usual activities) Level 5 (Unable: I am unable to do my usual activities)
12 months follow-up
Functional Scores - EQ5D-5L-PAIN/DISCOMFORT
The EQ-5D-5L Pain/Discomfort dimension assesses the severity of pain and physical discomfort across five levels, ranging from no problems to extreme problems. It measures how often or intensely a patient experiences pain, itching, or other physical sensations (excluding mental distress), providing a 5-level, more sensitive scale than the 3L version. Level 1 (I have no pain or discomfort) Level 2 (I have slight pain or discomfort) Level 3 (I have moderate pain or discomfort) Level 4 (I have severe pain or discomfort) Level 5 (I have extreme pain or discomfort)
2 months follow-up
Functional Scores - EQ5D-5L-PAIN/DISCOMFORT
The EQ-5D-5L Pain/Discomfort dimension assesses the severity of pain and physical discomfort across five levels, ranging from no problems to extreme problems. It measures how often or intensely a patient experiences pain, itching, or other physical sensations (excluding mental distress), providing a 5-level, more sensitive scale than the 3L version. Level 1 (I have no pain or discomfort) Level 2 (I have slight pain or discomfort) Level 3 (I have moderate pain or discomfort) Level 4 (I have severe pain or discomfort) Level 5 (I have extreme pain or discomfort)
6 months follow-up
Functional Scores - EQ5D-5L-PAIN/DISCOMFORT
The EQ-5D-5L Pain/Discomfort dimension assesses the severity of pain and physical discomfort across five levels, ranging from no problems to extreme problems. It measures how often or intensely a patient experiences pain, itching, or other physical sensations (excluding mental distress), providing a 5-level, more sensitive scale than the 3L version. Level 1 (I have no pain or discomfort) Level 2 (I have slight pain or discomfort) Level 3 (I have moderate pain or discomfort) Level 4 (I have severe pain or discomfort) Level 5 (I have extreme pain or discomfort)
12 months follow-up
Functional Scores - EQ5D-5L ANXIETY/DEPRESSION
The EQ5D-5L Anxiety/Depression dimension assesses the emotional/psychological component of health-related quality of life. It is often used to determine if mental health symptoms amplify reported physical health issues. It measures self-reported levels of anxiety and depression in five severity levels. Level 1 (I am not anxious or depressed) Level 2 (I am slightly anxious or depressed) Level 3 (I am moderately anxious or depressed) Level 4 (I am severely anxious or depressed) Level 5 (I am extremely anxious or depressed)
2 months follow-up
Functional Scores - EQ5D-5L ANXIETY/DEPRESSION
The EQ5D-5L Anxiety/Depression dimension assesses the emotional/psychological component of health-related quality of life. It is often used to determine if mental health symptoms amplify reported physical health issues. It measures self-reported levels of anxiety and depression in five severity levels. Level 1 (I am not anxious or depressed) Level 2 (I am slightly anxious or depressed) Level 3 (I am moderately anxious or depressed) Level 4 (I am severely anxious or depressed) Level 5 (I am extremely anxious or depressed)
6 months follow-up
Functional Scores - EQ5D-5L ANXIETY/DEPRESSION
The EQ5D-5L Anxiety/Depression dimension assesses the emotional/psychological component of health-related quality of life. It is often used to determine if mental health symptoms amplify reported physical health issues. It measures self-reported levels of anxiety and depression in five severity levels. Level 1 (I am not anxious or depressed) Level 2 (I am slightly anxious or depressed) Level 3 (I am moderately anxious or depressed) Level 4 (I am severely anxious or depressed) Level 5 (I am extremely anxious or depressed)
12 months follow-up
Walking Function - Timed-Up-and-Go (TUG)
The Timed-Up-and-Go (TUG) test is a quick, 3-meter walk assessment measuring functional mobility, balance, and fall risk in older adults. Patient starts seated, wearing regular footwear and using their usual walking aid (if needed). Then, the patient rises from a chair, walks 3 meters at a normal pace, turns, walks back, and sits down. Times less than or equivalent to 12 seconds indicate normal, while times greater than or equivalent to 20 seconds signify high fall risk. Scoring and Interpretation \< 10 seconds (Normal) \< 20 seconds (Independent and generally considered within normal limits for frail elderly) \> 20 seconds (Limited functional independence; high fall risk) \> 30 seconds (High risk of falling, often requiring assistance)
2 months follow-up
Walking Function - Timed-Up-and-Go (TUG)
The Timed-Up-and-Go (TUG) test is a quick, 3-meter walk assessment measuring functional mobility, balance, and fall risk in older adults. Patient starts seated, wearing regular footwear and using their usual walking aid (if needed). Then, the patient rises from a chair, walks 3 meters at a normal pace, turns, walks back, and sits down. Times less than or equivalent to 12 seconds indicate normal, while times greater than or equivalent to 20 seconds signify high fall risk. Scoring and Interpretation \< 10 seconds (Normal) \< 20 seconds (Independent and generally considered within normal limits for frail elderly) \> 20 seconds (Limited functional independence; high fall risk) \> 30 seconds (High risk of falling, often requiring assistance)
6 months follow-up
Walking Function - Timed-Up-and-Go (TUG)
The Timed-Up-and-Go (TUG) test is a quick, 3-meter walk assessment measuring functional mobility, balance, and fall risk in older adults. Patient starts seated, wearing regular footwear and using their usual walking aid (if needed). Then, the patient rises from a chair, walks 3 meters at a normal pace, turns, walks back, and sits down. Times less than or equivalent to 12 seconds indicate normal, while times greater than or equivalent to 20 seconds signify high fall risk. Scoring and Interpretation \< 10 seconds (Normal) \< 20 seconds (Independent and generally considered within normal limits for frail elderly) \> 20 seconds (Limited functional independence; high fall risk) \> 30 seconds (High risk of falling, often requiring assistance)
12 months follow-up
Contact the study team to confirm eligibility.
Primary Completion
June 8, 2023
Actual (reported)Study Completion
June 8, 2023
Actual (reported)Last Updated
October 23, 2026
Results First Posted
October 23, 2026
Record last verified: 2026-06
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: